{"version":"1.0","type":"link","title":"Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.","author_name":"Shanmuganathan N 외","author_url":"https://prs-insight.online/author/Shanmuganathan%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/164937","thumbnail_width":1200,"thumbnail_height":630}